Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 55, Issue 7, 1996, Pages 442-449

  Sugiyama, Masayasu ^a   Tsukazaki, Tomoo ^b,c   Yonekura, Akihiko ^a   Matsuzaki, Sumihiro ^a   Yamashita, Shunichi ^b   Iwasaki, Katsuro ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Department of Cell Physiology ^*  (Japan)

^c NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

EID: 0029970154     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.7.442     Document Type: Article

References (40)

1. Kerr J F R, Wyllie A H, Currie A R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
2. Majno G, Joris L. Apoptosis, oncosis, and necrosis: a preview of cell death. Am J Path 1995; 146: 3-15.
3. Wylie A H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-6.
4. Wylie A H, Morris R G, Smith A L, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 67-77.
5. Gavrieli Y, Sherman Y, Ben-Sasson S A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
6. Carson D A, Ribeiro J M. Apoptosis and disease. Lancet 1993; 341: 1251-4.
7. Thompson C B. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-62.
8. Fox R I, Kang H. Structure and function of synoviocytes. In: McCarty D J, Koopman W J, eds. Arthritis and allied conditions. Pennsylvania: Lea & Febiger, 1993; 263-78.
9. Case J P, Lafyatis R, Remmers E F, Kumkumian G K, Wilder R L. Transin/stromelysin expression in rheumatoid synovium: a transformation-associated metallo-proteinase secreted by phenotypically invasive synoviocytes. Am J Path 1989; 135: 1055-64.
10. Pelletier J P, Faure M P, DiBattista J A, Wilhelm S, Visco D, Pelletier J M. Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. Am J Path 1993; 142: 95-105.
11. Berg E, Wainwright R, Barton B, Puchtler H, McDonald T On the nature of rheumatoid rice bodies: an immunological, histochemical and electronmicroscopic study. Arthritis Rheum 1977; 20: 1343-9.
12. McCarty D J, Cheung H S. Origin and significance of rice bodies in synovial fluid. Lancet 1982; 2: 715.
13. Fassbender H G. Is pannus a residue of inflammation? Arthritis Rheum 1984; 27: 956-7.
14. Arnett F C, Edworthy S M, Bloch D A, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
15. Kinouchi T, Saiki S, Naoe T, et al. Correlation of c-myc expression with nuclear pleomorphism in human renal cell carcinoma. Cancer Res 1989; 49: 3627-30.
16. Schmitz G G, Walter T, Seibl R, Kessler C. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal Biochem 1991; 192: 222-31.
17. Mohr W, Beneke G, Mohing W. Proliferation of synovial lining cells and fibroblasts. Ann Rheum Dis 1975; 34: 219-24.
18. Henderson B, Glynn L E, Chayen J. Cell division in the synovial lining in experimental allergic arthritis: proliferation of cells during the development of chronic arthritis. Ann Rheum Dis 1982; 41: 275-81.
19. Krey P R, Cohen A S, Smith C B, Finland M. The human fetal synovium. Histology, fine structure and changes in organ culture. Arthritis Rheum 1971; 14: 319-25.
20. Edwards J C W, Willoughby D A. Demonstration of bone marrow-derived cells in synovial lining by means of giant intracellular granules as genetic markers. Ann Rheum Dis 1982; 41: 177-82.
21. Qu Z, Garcia C H, O'Rourke L M, Planck S R, Kohli M, Rosenbaum J T. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum 1994; 37: 212-20.
22. Nakajima T, Aono H, Hasumura T, et al. Apoptosis and functional fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995; 38: 485-91.
23. Firestein G S, Yeo M, Zvaifler N J. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995; 96: 1631-8.
24. Trabandt A, Aicher W K, Gay R E, et al. Expression of the collagenolytic and ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis. Matrix 1990; 10: 349-61.
25. Colby W W, Chen E Y, Smith D H, Levinson A D. Indentifincation and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. Nature 1983; 301: 722-5.
26. Evan G I, Wyllie A H, Gilben C S, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-28.
27. Yonishi-Rouach E, Grunwald E D, Wilder S, et al. p-53 mediated cell death: relationship to cell cycle control. Mol Cell Biol 1993; 13: 1415-23.
28. Maltzman W, Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cell. Mol Cell Biol 1984; 4: 1689-94.
29. Hermeking H, Eick D. Mediation of c-myc-induced apoptosis by p53. Science 1994; 265: 2091-3.
30. Eizenberg O, Elman A F, Gottlieb E, Oren M, Rotter V, Schwaltz M. Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J 1995; 14: 1136-44.
31. EI-Deiry W S, Tokino T, Velculescu V E, et al. Waf-1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-25.
32. Xiong Y, Hannon G J, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701-4.
33. Harper J W, Adami G R, Wei N, Keyomarsi K, Elledge S. The p21 Cdk-interacting protein Cip1 is a patent inhibitor of G1 cyclin-dependent kinsases. Cell 1993; 75: 805-16.
34. Parker S B, Eichele G, Zhang P, et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 1995; 267: 1024-7.
35. WAF1/CIP1 expression in normal and neoplasmic tissues. Cancer Res 1993; 55: 2910-9.
36. Korsmeyer S J. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80: 879-86.
37. Hockenbery D M, Oltvai Z N, Yin X M, Milliman C L, Korsmeyer S J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-51.
38. Poole A R. Cartilage in health and disease. In: McCarty D J, Koopman W J, eds. Arihritis and allied conditions. Pennsylvania: Lea & Febiger, 1993; 279-333.
39. Edwards J C, Cambridge J. Is rheumatoid arthritis a failure of B cell death in synovium? Ann Rheum Dis 1995; 54: 696-700.
40. Vaux D L, Cory S, Adams J M. Bcl-2 promotes the survival of haemopoietic cells and cooperates with c-myc to immortalize pre-B cells, Nature 1988; 335: 440-2.